Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19.
Schumann S, Kaiser A, Nicoletti F, Mangano K, Fagone P, van Wijk E, Yan Y, Schulz P, Ludescher B, Niedermaier M, von Wegerer J, Rauch P, Setz C, Schubert U, Brysch W. Schumann S, et al. Among authors: fagone p. Int J Mol Sci. 2020 Nov 20;21(22):8803. doi: 10.3390/ijms21228803. Int J Mol Sci. 2020. PMID: 33233817 Free PMC article.
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1.
Fagone P, Mangano K, Quattrocchi C, Motterlini R, Di Marco R, Magro G, Penacho N, Romao CC, Nicoletti F. Fagone P, et al. Clin Exp Immunol. 2011 Mar;163(3):368-74. doi: 10.1111/j.1365-2249.2010.04303.x. Epub 2011 Jan 14. Clin Exp Immunol. 2011. PMID: 21235533 Free PMC article.
In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells.
Donia M, Maksimovic-Ivanic D, Mijatovic S, Mojic M, Miljkovic D, Timotijevic G, Fagone P, Caponnetto S, Al-Abed Y, McCubrey J, Stosic-Grujicic S, Nicoletti F. Donia M, et al. Among authors: fagone p. Cell Cycle. 2011 Feb 1;10(3):492-9. doi: 10.4161/cc.10.3.14727. Epub 2011 Feb 1. Cell Cycle. 2011. PMID: 21270522
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse.
Kosiewicz MM, Auci DL, Fagone P, Mangano K, Caponnetto S, Tucker CF, Azeem N, White SK, Frincke JM, Reading CL, Nicoletti F. Kosiewicz MM, et al. Among authors: fagone p. Eur J Pharmacol. 2011 May 11;658(2-3):257-62. doi: 10.1016/j.ejphar.2011.02.016. Epub 2011 Mar 1. Eur J Pharmacol. 2011. PMID: 21371458
mTOR as a multifunctional therapeutic target in HIV infection.
Nicoletti F, Fagone P, Meroni P, McCubrey J, Bendtzen K. Nicoletti F, et al. Among authors: fagone p. Drug Discov Today. 2011 Aug;16(15-16):715-21. doi: 10.1016/j.drudis.2011.05.008. Epub 2011 May 23. Drug Discov Today. 2011. PMID: 21624501 Free article.
Therapeutic potential of carbon monoxide in multiple sclerosis.
Fagone P, Mangano K, Coco M, Perciavalle V, Garotta G, Romao CC, Nicoletti F. Fagone P, et al. Clin Exp Immunol. 2012 Feb;167(2):179-87. doi: 10.1111/j.1365-2249.2011.04491.x. Clin Exp Immunol. 2012. PMID: 22235993 Free PMC article. Review.
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells.
Donia M, Mangano K, Fagone P, De Pasquale R, Dinotta F, Coco M, Padron J, Al-Abed Y, Giovanni Lombardo GA, Maksimovic-Ivanic D, Mijatovic S, Zocca MB, Perciavalle V, Stosic-Grujicic S, Nicoletti F. Donia M, et al. Among authors: fagone p. Oncol Rep. 2012 Aug;28(2):682-8. doi: 10.3892/or.2012.1840. Epub 2012 May 29. Oncol Rep. 2012. PMID: 22665020
135 results